These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21472226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sann-Joong-Kuey-Jian-Tang up-regulates the protein expression of Fas and TNF-α in colo 205 cells in vivo and in vitro.
    Cheng CY, Lin YH, Su CC.
    Mol Med Rep; 2010; 3(1):63-7. PubMed ID: 21472201
    [Abstract] [Full Text] [Related]

  • 3. Sann-Joong-Kuey-Jian-Tang increases the protein expression of microtubule-associated protein II light chain 3 in human colon cancer colo 205 cells.
    Cheng CY, Lin YH, Su CC.
    Mol Med Rep; 2009; 2(5):707-11. PubMed ID: 21475889
    [Abstract] [Full Text] [Related]

  • 4. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
    Chen YL, Yan MY, Chien SY, Kuo SJ, Chen DR, Cheng CY, Su CC.
    Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
    [Abstract] [Full Text] [Related]

  • 5. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of mammalian target of rapamycin but increases microtubule associated protein II light chain 3 expression to inhibit human BxPC‑3 pancreatic carcinoma cells.
    Su CC.
    Mol Med Rep; 2015 Apr; 11(4):3160-6. PubMed ID: 25516264
    [Abstract] [Full Text] [Related]

  • 6. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl‑1 and TCTP and increases that of TNF-α and Bax in BxPC‑3 pancreatic carcinoma cells.
    Chien SY, Kuo SJ, Chen DR, Su CC.
    Int J Mol Med; 2013 Jul; 32(1):85-92. PubMed ID: 23652631
    [Abstract] [Full Text] [Related]

  • 7. Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways.
    Chuang WL, Su CC, Lin PY, Lin CC, Chen YL.
    Mol Med Rep; 2015 Aug; 12(2):1677-84. PubMed ID: 25847489
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
    Su CC, Lin YH.
    Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
    [Abstract] [Full Text] [Related]

  • 11. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 13. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
    Al Safarjalani ON, Rais R, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of capsaicin on human colon cancer cells in vitro and colo 205 tumor xenografts in vivo.
    Lu HF, Chen YL, Yang JS, Yang YY, Liu JY, Hsu SC, Lai KC, Chung JG.
    J Agric Food Chem; 2010 Dec 22; 58(24):12999-3005. PubMed ID: 21082859
    [Abstract] [Full Text] [Related]

  • 15. Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II.
    Su CC.
    Exp Ther Med; 2012 Mar 22; 3(3):555-559. PubMed ID: 22969929
    [Abstract] [Full Text] [Related]

  • 16. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 May 22; 457():1-327. PubMed ID: 12587019
    [Abstract] [Full Text] [Related]

  • 17. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 22; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of Endostatin and SU6668 combined with 5-FU on human colon cancer xenograft in nude mice].
    Zeng QL, Chu ZH, Zhou K, Luo XJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 22; 11(4):376-8. PubMed ID: 18636363
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR, Tortora G.
    Clin Cancer Res; 1999 Apr 22; 5(4):909-16. PubMed ID: 10213228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.